ESCRS Homepage

June 2003
IN THIS ISSUE

Corneal pachymetry proves key to glaucoma diagnosis


Probing physiology behind accommodative lens implants

Intralase cuts enhancement rates by 30% after LASIK

‘Quality of vision’ in sharp focus as four Main Symposia frame XXI ESCRS Congress

Allegretto laser works well for both hyperopia
and myopia correction, says FDA trial data

Innovative impulse device enables tongue to ‘see’ by processing sensory data to the brain

Increased precision of eye tracking module vital for customised ablations of large corneal areas

New adaptive optics system reduces higher order aberrations and previews custom ablation outcomes

High-resolution WASCA system shows good refractive outcomes for customised ablation

Results of prevalence studies casts link between ocular pressure and glaucoma in new light

New phakic IOL ‘gives good refractive outcome and is very well tolerated’, says specialist

Myopes are more likely to develop vitreoretinal complications than hyperopes after lens exchange

Preoperative myopia proves a good outcome predictor for LASIK surgery

Broad beam laser with Gaussian delivery obviates need for eye tracker in LASEK procedures

Modified approach needed for IOL power readings in post-RK eyes to cut risk of hyperopic outcome

Block excision therapy of choice for epithelial in-growth

CLAPIKS offers novel pharmacological approach for treatment the hyperopia after LASIK surgey

Study shows LASIK could provide long-term savings to patients despite initial costs

Theories take shape to unravel mystery of presbyopia development in the human eye

Retinal detachment risk in high myopes unaltered by excimer laser vision correction procedure

Ocular surgery patients advised to avoid risk of infection by staying away from swimming pools

Personalised iris prosthesis comes a shade closer to the ideal coloured iris solution

FEATURES
From The Editor
Guest Editorial
Reflections on Refractive Surgery
Bio-Ophthalmology
In Your Good Books
Bio-ophthalmology
Digital Opthalmologist
Regulatory Matters


Guest Editorial: What can the ESCRS teach the EU?

THE recent decision to admit 10 new nations into the European Union is an exciting political development which gives reason to pause and ask ourselves what it means to be a European and, in particular, what it means to be a European ophthalmologist. I would emphasise that while we can certainly learn something from the EU, the EU can also learn something from the experience of the ESCRS.

Like the EU, the ESCRS includes members from diverse political, economic and social backgrounds. And like the EU, the ESCRS membership has been expanding steadily. Indeed, the ESCRS could be seen to have blazed the trail in advance of the EU expansion, considering that we have had members from the all of the EU countries, old and new, for many years.

Fortunately, we did not wait for the politicians or for the European bureaucracy to unite the field of European ophthalmology. The ESCRS began its existence 25 years ago as a small professional organisation and has grown in size and influence in the intervening years.

I’m also glad to say that there is a high level of co-operation between our organisation and related groups such as the European Society of Ophthalmology and the European Contact Lens Society of Ophthalmologists.

In my view, we do not need more instructions, rules, regulations and so on from the EU in Brussels. Rather, they need our advice on facilitating communication and mutual benefits for a diverse group of people united by common interests. Our policy is based on mutual respect and understanding for all of our members, appreciating the differences and making the most of the similarities.

Concrete examples of this approach include our annual conferences, our journal and this news magazine, as well as ambitious pan-European research projects such as the ongoing European Cataract Outcomes Study Group and the recently initiated endophthalmitis prophylaxis study. It should also be noted that, lacking any financial largess from the EU, we accomplish our goals in a remarkably efficient and cost-effective manner.

As Europe evolves, so too does the ESCRS. We can no longer remain in our ivory towers. All of us are aware of the growing economic pressures facing medical care in Europe. We must pursue a strong policy of lobbying the EU to make sure our needs, and those of our patients, are understood. As a part of this objective, we will pursue a policy of closer links with national ophthalmology societies. Closer links with our colleagues will help us to exert greater influence at EU level.

The EU is poised to play a greater role in medical research. This is one area in which we should concentrate our lobbying. The EU says it will provide more financial resources for conducting research, but has not spelled out how it will do so. Working with our colleagues, we can help the EU understand where to allocate these funds for important ophthalmological research.

The EU is also going to play an increasing role in the regulation of health care. We want to make sure that our patients are protected from malpractice. We also want to make sure that the highest standards of care are maintained. We also look forward to a European-wide system of clinical evaluation of new medications and, equally important, of new medical devices.

These are not tasks only for the president and board, but for all members of the ESCRS. I look forward to hearing your comments on how the ESCRS can best serve the needs of our growing membership. Your effort is greatly appreciated. Your effort is greatly needed.

Top